TY - JOUR AU - Mirghani, H. AU - Bellera, C. AU - Delaye, J. AU - Dolivet, G. AU - Fakhry, N. AU - Bozec, A. PY - 2019 DA - 2019// TI - Prevalence and characteristics of HPV-driven oropharyngeal cancer in France JO - Cancer Epidemiol. VL - 61 UR - https://doi.org/10.1016/j.canep.2019.05.007 DO - 10.1016/j.canep.2019.05.007 ID - Mirghani2019 ER - TY - JOUR AU - Broglie, M. A. AU - Stoeckli, S. J. AU - Sauter, R. AU - Pasche, P. AU - Reinhard, A. AU - Leval, L. PY - 2017 DA - 2017// TI - Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery JO - Head Neck. VL - 39 UR - https://doi.org/10.1002/hed.24865 DO - 10.1002/hed.24865 ID - Broglie2017 ER - TY - JOUR AU - Chaturvedi, A. K. AU - Engels, E. A. AU - Pfeiffer, R. M. AU - Hernandez, B. Y. AU - Xiao, W. AU - Kim, E. PY - 2011 DA - 2011// TI - Human papillomavirus and rising oropharyngeal cancer incidence in the United States JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2011.36.4596 DO - 10.1200/JCO.2011.36.4596 ID - Chaturvedi2011 ER - TY - JOUR AU - Escott, E. J. PY - 2013 DA - 2013// TI - Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer JO - Radiol Clin North Am. VL - 51 UR - https://doi.org/10.1016/j.rcl.2013.05.002 DO - 10.1016/j.rcl.2013.05.002 ID - Escott2013 ER - TY - STD TI - Helsen N, Van den Wyngaert T, Carp L, De Bree R, VanderVeken OM, De Geeter F, et al. Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study. Eur J Nucl Med Mol Imaging. 2020. https://doi.org/10.1007/s00259-020-04710-4. ID - ref5 ER - TY - JOUR AU - Rohde, M. AU - Dyrvig, A. K. AU - Johansen, J. AU - Sorensen, J. A. AU - Gerke, O. AU - Nielsen, A. L. PY - 2014 DA - 2014// TI - 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis JO - Eur J Cancer. VL - 50 UR - https://doi.org/10.1016/j.ejca.2014.05.015 DO - 10.1016/j.ejca.2014.05.015 ID - Rohde2014 ER - TY - JOUR AU - Wyngaert, T. AU - Helsen, N. AU - Carp, L. AU - Hakim, S. AU - Martens, M. J. AU - Hutsebaut, I. PY - 2017 DA - 2017// TI - Fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: the ECLYPS study JO - J Clin Oncol. VL - 35 UR - https://doi.org/10.1200/JCO.2017.73.5845 DO - 10.1200/JCO.2017.73.5845 ID - Wyngaert2017 ER - TY - JOUR AU - Beer, A. J. AU - Grosu, A. L. AU - Carlsen, J. AU - Kolk, A. AU - Sarbia, M. AU - Stangier, I. PY - 2007 DA - 2007// TI - [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck JO - Clin Cancer Res. VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0528 DO - 10.1158/1078-0432.CCR-07-0528 ID - Beer2007 ER - TY - JOUR AU - Beer, A. J. AU - Haubner, R. AU - Goebel, M. AU - Luderschmidt, S. AU - Spilker, M. E. AU - Wester, H. J. PY - 2005 DA - 2005// TI - Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients JO - J Nucl Med. VL - 46 ID - Beer2005 ER - TY - JOUR AU - Beer, A. J. AU - Haubner, R. AU - Sarbia, M. AU - Goebel, M. AU - Luderschmidt, S. AU - Grosu, A. L. PY - 2006 DA - 2006// TI - Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man JO - Clin Cancer Res. VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0266 DO - 10.1158/1078-0432.CCR-06-0266 ID - Beer2006 ER - TY - JOUR AU - Schnell, O. AU - Krebs, B. AU - Carlsen, J. AU - Miederer, I. AU - Goetz, C. AU - Goldbrunner, R. H. PY - 2009 DA - 2009// TI - Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography JO - Neuro Oncol. VL - 11 UR - https://doi.org/10.1215/15228517-2009-024 DO - 10.1215/15228517-2009-024 ID - Schnell2009 ER - TY - JOUR AU - Beer, A. J. AU - Niemeyer, M. AU - Carlsen, J. AU - Sarbia, M. AU - Nahrig, J. AU - Watzlowik, P. PY - 2008 DA - 2008// TI - Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET JO - J Nucl Med. VL - 49 UR - https://doi.org/10.2967/jnumed.107.045526 DO - 10.2967/jnumed.107.045526 ID - Beer2008 ER - TY - JOUR AU - Al-Abd, A. M. AU - Alamoudi, A. J. AU - Abdel-Naim, A. B. AU - Neamatallah, T. A. AU - Ashour, O. M. PY - 2017 DA - 2017// TI - Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies - a review JO - J Adv Res. VL - 8 UR - https://doi.org/10.1016/j.jare.2017.06.006 DO - 10.1016/j.jare.2017.06.006 ID - Al-Abd2017 ER - TY - STD TI - Kong DH, Kim MR, Jang JH, Na HJ, Lee S. A review of anti-angiogenic targets for monoclonal antibody cancer therapy. Int J Mol Sci. 2017;18. https://doi.org/10.3390/ijms18081786. ID - ref14 ER - TY - JOUR AU - Zhernosekov, K. P. AU - Filosofov, D. V. AU - Baum, R. P. AU - Aschoff, P. AU - Bihl, H. AU - Razbash, A. A. PY - 2007 DA - 2007// TI - Processing of generator-produced 68Ga for medical application JO - J Nucl Med. VL - 48 UR - https://doi.org/10.2967/jnumed.107.040378 DO - 10.2967/jnumed.107.040378 ID - Zhernosekov2007 ER - TY - JOUR AU - Gnesin, S. AU - Mitsakis, P. AU - Cicone, F. AU - Deshayes, E. AU - Dunet, V. AU - Gallino, A. F. PY - 2017 DA - 2017// TI - First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK JO - EJNMMI Res. VL - 7 UR - https://doi.org/10.1186/s13550-017-0288-x DO - 10.1186/s13550-017-0288-x ID - Gnesin2017 ER - TY - JOUR AU - Gaertner, F. C. AU - Kessler, H. AU - Wester, H. J. AU - Schwaiger, M. AU - Beer, A. J. PY - 2012 DA - 2012// TI - Radiolabelled RGD peptides for imaging and therapy JO - Eur J Nucl Med Mol Imaging. VL - 39 UR - https://doi.org/10.1007/s00259-011-2028-1 DO - 10.1007/s00259-011-2028-1 ID - Gaertner2012 ER - TY - JOUR AU - Zhai, C. AU - Franssen, G. M. AU - Petrik, M. AU - Laverman, P. AU - Summer, D. AU - Rangger, C. PY - 2016 DA - 2016// TI - Comparison of Ga-68-labeled fusarinine C-based multivalent RGD conjugates and [(68)Ga]NODAGA-RGD-in vivo imaging studies in human xenograft tumors JO - Mol Imaging Biol. VL - 18 UR - https://doi.org/10.1007/s11307-016-0931-3 DO - 10.1007/s11307-016-0931-3 ID - Zhai2016 ER - TY - JOUR AU - Gucht, A. AU - Pomoni, A. AU - Jreige, M. AU - Allemann, P. AU - Prior, J. O. PY - 2016 DA - 2016// TI - 68Ga-NODAGA-RGDyK PET/CT imaging in esophageal cancer: first-in-human imaging JO - Clin Nucl Med. VL - 41 UR - https://doi.org/10.1097/RLU.0000000000001365 DO - 10.1097/RLU.0000000000001365 ID - Gucht2016 ER - TY - JOUR AU - Haubner, R. AU - Finkenstedt, A. AU - Stegmayr, A. AU - Rangger, C. AU - Decristoforo, C. AU - Zoller, H. PY - 2016 DA - 2016// TI - [(68)Ga]NODAGA-RGD - metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis JO - Eur J Nucl Med Mol Imaging. VL - 43 UR - https://doi.org/10.1007/s00259-016-3396-3 DO - 10.1007/s00259-016-3396-3 ID - Haubner2016 ER - TY - JOUR AU - Isal, S. AU - Pierson, J. AU - Imbert, L. AU - Clement, A. AU - Collet, C. AU - Pinel, S. PY - 2018 DA - 2018// TI - PET imaging of (68)Ga-NODAGA-RGD, as compared with (18)F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma JO - EJNMMI Res. VL - 8 UR - https://doi.org/10.1186/s13550-018-0405-5 DO - 10.1186/s13550-018-0405-5 ID - Isal2018 ER - TY - JOUR AU - Pohle, K. AU - Notni, J. AU - Bussemer, J. AU - Kessler, H. AU - Schwaiger, M. AU - Beer, A. J. PY - 2012 DA - 2012// TI - 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process JO - Nucl Med Biol. VL - 39 UR - https://doi.org/10.1016/j.nucmedbio.2012.02.006 DO - 10.1016/j.nucmedbio.2012.02.006 ID - Pohle2012 ER - TY - JOUR AU - Liu, J. F. AU - Deng, W. W. AU - Chen, L. AU - Li, Y. C. AU - Wu, L. AU - Ma, S. R. PY - 2018 DA - 2018// TI - Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer JO - Mol Carcinog. VL - 57 UR - https://doi.org/10.1002/mc.22767 DO - 10.1002/mc.22767 ID - Liu2018 ER - TY - JOUR AU - Knetsch, P. A. AU - Petrik, M. AU - Griessinger, C. M. AU - Rangger, C. AU - Fani, M. AU - Kesenheimer, C. PY - 2011 DA - 2011// TI - [68Ga]NODAGA-RGD for imaging alphavbeta3 integrin expression JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1778-0 DO - 10.1007/s00259-011-1778-0 ID - Knetsch2011 ER - TY - JOUR AU - Terry, S. Y. AU - Abiraj, K. AU - Frielink, C. AU - Dijk, L. K. AU - Bussink, J. AU - Oyen, W. J. PY - 2014 DA - 2014// TI - Imaging integrin alphavbeta3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts JO - J Nucl Med. VL - 55 UR - https://doi.org/10.2967/jnumed.113.129668 DO - 10.2967/jnumed.113.129668 ID - Terry2014 ER - TY - JOUR AU - Okami, K. PY - 2016 DA - 2016// TI - Clinical features and treatment strategy for HPV-related oropharyngeal cancer JO - Int J Clin Oncol. VL - 21 UR - https://doi.org/10.1007/s10147-016-1009-6 DO - 10.1007/s10147-016-1009-6 ID - Okami2016 ER - TY - JOUR AU - Terry, S. Y. AU - Abiraj, K. AU - Lok, J. AU - Gerrits, D. AU - Franssen, G. M. AU - Oyen, W. J. PY - 2014 DA - 2014// TI - Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts? JO - J Nucl Med. VL - 55 UR - https://doi.org/10.2967/jnumed.114.144394 DO - 10.2967/jnumed.114.144394 ID - Terry2014 ER - TY - JOUR AU - Chen, S. H. AU - Wang, H. M. AU - Lin, C. Y. AU - Chang, J. T. AU - Hsieh, C. H. AU - Liao, C. T. PY - 2016 DA - 2016// TI - RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: results from a pilot study JO - Eur J Nucl Med Mol Imaging. VL - 43 UR - https://doi.org/10.1007/s00259-016-3345-1 DO - 10.1007/s00259-016-3345-1 ID - Chen2016 ER -